戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              PGI has been used to map a total of 3858 BAC clones cove
2                                              PGI is a multifunctional dimeric protein that extracellu
3                                              PGI is a multifunctional dimeric protein that extracellu
4                                              PGI is a multifunctional dimeric protein that extracellu
5                                              PGI phosphorylation by CK2 also led to down-regulation o
6                                              PGI(2) (prostacyclin) is a lipid mediator with vasodilat
7                                              PGI(2) is also increasingly believed to have anti-inflam
8                                              PGI(2) plays a key role in limiting Th2-mediated airway
9                                              PGI-02776 was also readily hydrolyzed to both the mono-e
10                                              PGI-LysAP hydrolyzed bradykinin, Lys-bradykinin, Lys-(de
11                                              PGI-overexpressing cells also exhibited elevated express
12                                              PGI/AMF cellular expression in HT1080 human fibrosarcoma
13                                              PGI/AMF has been correlated significantly with breast ca
14 mbination of PGI/II-HpAb (0.786, P < 0.001), PGI/II-OPN (0.787, P < 0.001), and OPN-HpAb (0.801, P =
15 shold (P = 0.002), CGI-Severity (P = 0.048), PGI-Improvement (P = 0.033), and several quality-of-life
16 ese results suggest that activation of COX-1/PGI(2)/PPARdelta pathway is an important mechanism under
17                                      PARP-14-PGI/AMF interaction was confirmed by coimmunoprecipitati
18 -M), and PGI2, 2,3-dinor 6-keto PGF(1alpha) (PGI-M), only PGI-M was depressed by the COX-2 inhibitor.
19  B2 (Tx-M) and 2'3-donor-6-keto-PGF(1alpha) (PGI-M).
20 elease and production of prostaglandin I(2) (PGI(2)) and platelet-activating factor (PAF).
21                          Prostaglandin I(2) (PGI(2)) stimulated VEGF-dependent angiogenesis to preven
22 such as nitric oxide and prostaglandin I(2) (PGI(2)), considerably less is known about intrinsic mech
23  increases production of prostaglandin I(2) (PGI(2)).
24 tabolism via stimulation of cyclooxygenase-2/PGI(2) synthase pathway.
25 muM) to the reference drug nitazoxanide (50% PGI release at c = 1.2 muM).
26 , Ph) with comparable in vitro toxicity (50% PGI release at c = 1.4 - 4.7 muM) to the reference drug
27 oprostol (a PGE(1/2) analog) or beraprost (a PGI(2) analog) significantly decreased ConA-induced live
28 gh-salt diet (HSD); this was attenuated by a PGI(2) receptor agonist.
29 t AAMvarphi-derived eicosanoid and propose a PGI(2)-PPARdelta axis maintains AAMvarphi during B malay
30 cident with TP-cAMP generation, promoting a "PGI(2)-like" cellular response to TP activation.
31          Furthermore, unlike the activators (PGI(2) and forskolin) of the cAMP pathway, 2MeSAMP and C
32 latory properties of clinically administered PGI(2) analogs.
33                                          AMF/PGI acts extracellularly as a potent mitogen/cytokine (C
34            Because little is known about AMF/PGI-dependent signaling in general and during tumorigene
35                  Increased expression of AMF/PGI and its receptor/CXXC-R has been found in a wide spe
36 irectly elucidate the functional role of AMF/PGI on cell motility and neoplastic transformation, we s
37                Ectopic overexpression of AMF/PGI results in its secretion and activation via a consti
38             The transformed phenotype of AMF/PGI-transfected cells leads in part resistance to induct
39 ic transformation, we stably transfected AMF/PGI cDNA into NIH-3T3 cells.
40 ucose isomerase with a lysyl aminopeptidase (PGI-LysAP) activity was identified in Vibrio vulnificus.
41 d protein expression of cyclooxygenase-2 and PGI(2) in adventitia, media, and endothelium.
42 also caused increase in cyclooxygenase-2 and PGI(2) synthase protein expression associated with eleva
43 Ang2 and the hypoxic induction of PGE(2) and PGI(2) in a dose-dependent manner.
44 whereas it augmented excretion of PGD(2) and PGI(2) metabolites, reflecting rediversion of the accumu
45 S-stimulated COX-2 expression and PGE(2) and PGI(2) production.
46 I, whereas celecoxib blocked both PGE(2) and PGI(2) production.
47 eased expression of mRNA encoding PGE(2) and PGI(2) synthases.
48                Finally, exogenous PGE(2) and PGI(2) were able to stimulate Ang2 under normoxic condit
49 ed increases in the production of PGE(2) and PGI(2) were associated with increased expression of mRNA
50                  Prostaglandin (PG) E(2) and PGI(2) were shown to be the major prostaglandin metaboli
51             Prostaglandins (PGs), PGE(2) and PGI(2), also accumulate in the interstitium during exerc
52 ediated through the production of PGE(2) and PGI(2), which exert anti-inflammatory functions.
53                 Measured PLA(2) activity and PGI(2) production by iPLA(2)beta-KO cells were suppresse
54  high levels of COX-1 protein expression and PGI(2) biosynthesis in human EPCs outgrown from blood mo
55  that PGE(2) released from muscle fibres and PGI(2) released from capillaries and venular endothelium
56 otogenic, and differentiation functions, and PGI has been implicated in tumor progression and metasta
57 n both angiotensin II-induced relaxation and PGI(2) release but also abolished high-glucose-enhanced
58                 Arachidonic acid release and PGI(2) production by stimulated iPLA(2)beta-KO endotheli
59 nt difference was found between sham-TBI and PGI-02776 treated groups in either analysis indicating a
60                                           As PGI(2) is unstable, we sought to define the effects of v
61 a), but not by other prostaglandins, such as PGI(2), TxB(2), or PGD(2).
62 GES-1 depressed PGE(2) expression, augmented PGI(2) expression, and had no effect on thromboxane bios
63 ic procedures, SIMCA achieved to be the best PGI-model with 93.3% of sensitivity and 100% of specific
64         Intron position is conserved between PGIs of Colias and the silkmoth, but no intron sequence
65                Augmented expressions of both PGI/AMF and AMFR have been implicated in tumor progressi
66 olytic cleavage of human-derived peptides by PGI-LysAP of V. vulnificus using three approaches: (i) a
67 gulates the expression level of tumor cells' PGI/AMF.
68 as associated with up-regulation of cellular PGI enzymatic activity.
69 and the Patient Global Impression of Change (PGI-C).
70 t are the hallmark of the well characterized PGI family.
71                                  Like Colias PGI's coding sequences, the introns evolve reticulately
72 on of the housekeeping gene product/cytokine PGI/AMF, and the results depicted here suggest a novel t
73 vestigated the impact of disrupted cytosolic PGI (cPGI) function on plant viability and metabolism.
74 2, arachidonic acid release, COX-2-dependent PGI(2) synthesis, and IP receptor-linked elevation of cA
75 regulated expression of the COX-2 dependent, PGI(2) biosynthesis/response pathway in the renal inner
76  NSAID-mediated suppression of COX-2-derived PGI(2) has negative cardiovascular consequences, yet lit
77  deletion of the receptor for PGHS-2-derived PGI(2), was shown to accelerate thrombogenesis and eleva
78       In contrast, the structurally distinct PGIs of eukaryotic or bacterial origin are thought to ca
79                                 The elevated PGI-M in smokers (189+/-25, median 174, range 85 to 390
80  human PGI/AMF down-regulated the endogenous PGI/AMF expression and completely extinguished the secre
81 PII inhibitor ZJ-43 and its prodrug di-ester PGI-02776 reduce the deleterious effects of excessive ex
82 n uninjured animals found that the di-ester (PGI-02776) crossed the blood-brain barrier.
83 ile the mono-ester (PGI-02749) and di-ester (PGI-02776) prodrug compounds exhibited moderate and weak
84 nt inhibitory activity while the mono-ester (PGI-02749) and di-ester (PGI-02776) prodrug compounds ex
85 o readily hydrolyzed to both the mono-ester (PGI-02749) and the parent compound (ZJ-43) in both blood
86 enzyme, compared to bacterial and eukaryotic PGIs.
87 se of equivalent complexes of the eukaryotic PGIs reveals similarities at the active site in the disp
88 ally high levels of endogenous and exogenous PGI/AMF, were stably transfected with PGI/AMF small inte
89 ect studies of the significance of exogenous PGI/AMF on tumor progression have been reported.
90 s in endothelial cells, and VSMCs expressing PGI synthase were enriched in mPGES-1(-/-) LDLR(-/-) les
91 glucose isomerase/autocrine motility factor (PGI/AMF) is a housekeeping gene product present in all c
92 glucose isomerase/autocrine motility factor (PGI/AMF) is a housekeeping gene product/cytokine that ca
93 glucose isomerase/autocrine motility factor (PGI/AMF) plays an important role in glycolysis and gluco
94 ntrast, the percentage of 18:0 was lower for PGI veal, and that of 18:1 c9 was higher in PDO veal, wh
95 terial content of cAMP, second messenger for PGI(2), were significantly augmented after transplantati
96 eural networks) to derive diverse models for PGI-honey class with the objective of detecting possible
97 nal medullary expression of the receptor for PGI(2), but not for other prostanoids, was depressed by
98 xamined the interaction of the receptors for PGI(2) (IP) and TxA(2) (TPalpha).
99 c inflammation, implying a critical role for PGI(2) in the programming of "natural" gammadelta-17 cel
100 od in order to differentiate between genuine PGI-Galician honey samples and other commercial honey sa
101 d as substrates for falsification of genuine PGI ones.
102                    The siRNA targeting human PGI/AMF down-regulated the endogenous PGI/AMF expression
103  activities, although it is known that human PGI/AMF is phosphorylated at Ser(185) by protein kinase
104                         Our results identify PGI(2)-IP as an important pathway for inhibiting allergi
105                                 Importantly, PGI(2) and its receptor IP, which downregulated airway e
106 e, Patient Global Impression of Improvement (PGI-Improvement) scale, Brief Pain Inventory (short form
107  these results suggest a role of miR-200s in PGI/AMF-induced EMT and thus approaches for upregulation
108 requires a rotation of its C2-C3 bond but in PGI this is sterically blocked by Gln511.
109  A proline residue (in place of a glycine in PGI) may also promote PMI activity by positioning the C1
110               Histamine-induced increases in PGI(2) and PGE(2) production were due to increased expre
111  reduced p27Kip1 protein expression level in PGI-overexpressing cells could be restored to control le
112  that the expression of miR-200s was lost in PGI/AMF overexpressing MCF-10A cells and in highly invas
113  increased superoxide and 3-nitrotyrosine in PGI(2) synthase (PGIS).
114 pendent kinase inhibitor was up-regulated in PGI/AMF knockdown cells and that superoxide dismutase is
115                                           In PGIs from bacterial and eukaryotic sources, which cannot
116  research supports a role for PGs, including PGI(2), in the regulation of both innate and acquired im
117 and macrophages with bacterial LPS increased PGI(2) and thromboxane A(2) to varied extents.
118 f EPCs promotes vasoprotection by increasing PGI(2) production and intracellular concentration of cAM
119                     Pooled genomic indexing (PGI) is a method for mapping collections of bacterial ar
120 's Mountain Protected Geographic Indication (PGI).
121 neys with protected geographical indication (PGI) "Mel de Galicia" was processed by means of differen
122  (PDO) or Protected Geographical Indication (PGI) product has also been discussed.
123 re administered the NAAG peptidase inhibitor PGI-02776 (10mg/kg) 30 min following TBI combined with a
124 e experiments revealed that PARP-14 inhibits PGI/AMF ubiquitination, thus contributing to its stabili
125 1-selective inhibitor, dramatically inhibits PGI(2) production.
126         Over the two weeks following injury, PGI-02776-treated rats had significantly improved motor
127          Furthermore, two weeks post-injury, PGI-02776-treated animals had a significant decrease in
128  depletion of glucose-6-phosphate isomerase (PGI) in the glucose-depleted Deltamec/Deltamec null back
129 thway and the glucose-6-phosphate isomerase (PGI) reaction.
130 ococcus litoralis, phosphoglucose isomerase (PGI) activity is catalyzed by an enzyme unrelated to the
131  through action of phosphoglucose isomerase (PGI) and phosphoglucose mutase interconverting glucose 6
132 ility factor (AMF)/phosphoglucose isomerase (PGI) is a ubiquitous cytosolic enzyme and is produced as
133                    Phosphoglucose isomerase (PGI) is an enzyme of glycolysis that interconverts gluco
134                    Phosphoglucose isomerase (PGI) is one of the glycolytic enzymes and is a multifunc
135 To pursue this for phosphoglucose isomerase (PGI) of Colias butterflies, whose polymorphism is mainta
136 ) by baker's yeast phosphoglucose isomerase (PGI) with regard to k(cat) and K(m) were determined from
137 a dual specificity phosphoglucose isomerase (PGI)/phosphomannose isomerase from Pyrobaculum aerophilu
138                    Phosphoglucose isomerase (PGI; EC 5.3.1.9) is a cytosolic housekeeping enzyme of t
139                    Phosphoglucose isomerase (PGI; EC 5.3.1.9) is a housekeeping cytosolic enzyme of t
140                    Phosphoglucose isomerase (PGI; EC 5.3.1.9) is a ubiquitous cytosolic enzyme essent
141                    Phosphoglucose isomerase, PGI, of Colias butterflies offers such a case.
142  commonly seen in phosphoglucose isomerases (PGIs) that are found in bacteria, eukaryotes and some ar
143 s at 24 h post injury revealed that 10 mg/kg PGI-02776 significantly decreased the number of degenera
144            Along with elevated COX-2 levels, PGI(2) and PGE(2) levels were also increased.
145           We identified the PPARdelta ligand PGI(2) as the most abundant AAMvarphi-derived eicosanoid
146                           Thus, PGD(2), like PGI(2), may function as a homeostatic response to thromb
147 e excretion, with the exception of the major PGI(2) metabolite that was suppressed on regular chow an
148 rotected by the European Union with the mark PGI (i.e., Protected Geographical Indication), and culti
149 consequences associated with PGHS-2-mediated PGI(2) suppression.
150 eats (n=68), "Vitela Tradicional do Montado"-PGI veal, Mertolenga-PDO veal and Mertolenga-PDO beef we
151  muscle cells generated less PGE(2) but more PGI(2) and expressed reduced tenascin-C compared with wi
152                                    Moreover, PGI(2) pretreatment of Th2 cells suppressed the ability
153 enzymatic activity, whereas the S185A mutant PGI protein retained full enzymatic activity.
154 /mg creatinine (P=0.002), and in nonsmokers, PGI-M at baseline (115+/-10, median 107, range 67 to 198
155 s2 and microsomal type PGE synthases but not PGI synthases are co-expressed.
156 nhibited prostaglandin E(2) (PGE(2)) but not PGI(2) production in response to Ang II, whereas celecox
157 GD(2), thromboxane, and PGF(2alpha), but not PGI(2).
158 wever, here we have shown that activation of PGI(2) receptor (IP) upregulated the expression of sever
159 rylation modulates the enzymatic activity of PGI thus has an important implication for the understand
160                              The addition of PGI 2 alone also induced the expression of VEGF.
161                            Administration of PGI-02776 immediately following the cessation of hypoxia
162     Conversely, iloprost, a stable analog of PGI(2), augmented IL-17 production by gammadelta T cells
163 madelta-17 cell responses, stable analogs of PGI(2) may be exploited in the development of new immuno
164 th suppression of PGE(2) and augmentation of PGI(2) attenuate tenascin-C expression and vascular smoo
165 801, P = 0.006), as well as one-biomarker of PGI/II (0.735, P < 0.001), HpAb (0.737, P < 0.001) and O
166 of a divergent impact on the biosynthesis of PGI(2).
167 ies are the first to explore the capacity of PGI(2) to regulate bacterial killing and phagocytosis in
168 y higher than two-dimensional combination of PGI/II-HpAb (0.786, P < 0.001), PGI/II-OPN (0.787, P < 0
169 er ROC from three-dimensional combination of PGI/II-HpAb-OPN (0.826) was significantly higher than tw
170                           The combination of PGI/II-HpAb-OPN, yielded a sensitivity of 70.2% and spec
171 hanisms involved in the counterregulation of PGI(2)/TxA(2) signaling are unclear.
172      We show here that ectopic expression of PGI/AMF induced epithelial-to-mesenchymal transition (EM
173 t under hypoxic conditions the expression of PGI/AMF is regulated in part by the HIF pathway, which i
174 enzyme unrelated to the well known family of PGI enzymes found in prokaryotes, eukaryotes, and some a
175 e enzyme, resulting in a less active form of PGI, whereas non-phosphorylated protein species retain c
176 cells and again the increase in formation of PGI(2) observed in WTs was suppressed in cells derived f
177 f accumulated PGH(2) to augment formation of PGI(2).
178 at mediate the anti-inflammatory function of PGI(2.) In this study, we determined that PGI(2) analogs
179 lating platelets by maximizing the impact of PGI(2).
180        In addition, the hypoxia induction of PGI/AMF expression was suppressed by inhibitors of vascu
181 r benefit, despite concomitant inhibition of PGI(2).
182 robic energy generation; thus, inhibition of PGI/AMF expression and activities may provide a new ther
183 n breast epithelial cells, and inhibition of PGI/AMF expression triggered mesenchymal-to-epithelial t
184 e a new therapeutic target for inhibition of PGI/AMF inducing tumor cell migration and invasion durin
185                      A specific inhibitor of PGI/AMF induced cellular senescence and p21 expression i
186 ogether, the results show the involvement of PGI/AMF in both EMT and MET: overexpression of PGI/AMF i
187  tumor cells, we examined the involvement of PGI/AMF in overcoming cellular senescence in cancer cell
188                   Homology-based modeling of PGI's structure shows that these regions are related spa
189                    Ectopic overexpression of PGI results in the acquisition of a transformed phenotyp
190 I/AMF in both EMT and MET: overexpression of PGI/AMF induces EMT in normal breast epithelial cells an
191 sis, and an intracellular binding partner of PGI/AMF is expected to regulate in part its diverse biol
192 mino acid variants occur in diverse parts of PGI's sequence.
193                  The increased production of PGI(2) and arterial content of cAMP were inhibited only
194                   Furthermore, production of PGI(2) and arterial content of cAMP, second messenger fo
195 d arachidonic acid release and production of PGI(2) and PAF.
196 in the expression of COX-2 and production of PGI(2) and PGE(2) with no significant change in the expr
197                            The production of PGI(2) leads to an increase in the level of the pro-angi
198 vel mechanism by which stromal production of PGI(2) promotes survival of colonocytes through PPAR del
199 ible Ha-Ras(V12) increases the production of PGI(2) through the coordinate up-regulation of cPLA(2),
200  that the phosphorylation mutant proteins of PGI exhibited decreased enzymatic activity, whereas the
201 mal breast epithelial cells and reduction of PGI/AMF expression led to MET in aggressive breast cance
202 le is known of the biochemical regulation of PGI/AMF activities, although it is known that human PGI/
203 1, which in turn led to the up-regulation of PGI/AMF expression and was specifically inhibited by inh
204 ld assist in understanding the regulation of PGI/AMF intracellular function(s) and may provide a new
205 ormal fibroblasts whereas down-regulation of PGI/AMF leads to mesenchymal-to-epithelial transition in
206          To elucidate the functional role of PGI, we stably transfected its cDNA into NIH/3T3 and BAL
207 and completely extinguished the secretion of PGI/AMF in a human fibrosarcoma HT1080, whereas the cont
208                                 Silencing of PGI/AMF expression by RNA interference in MDA-MB-231 cel
209                       Moreover, silencing of PGI/AMF expression in MDA-MB-231 cells led to overexpres
210 ther reexpression of miR-200 or silencing of PGI/AMF suppressed pulmonary metastases of MDA-MB-231 ce
211 re with G6P also explains the specificity of PGI for glucose 6-phosphate over mannose 6-isomerase (M6
212                               Suppression of PGI/AMF led to a contact-dependent inhibition of cell gr
213                 Furthermore, transfection of PGI(2) synthase siRNA, COX-1 siRNA, or PPARdelta siRNA i
214 f its fold, with the inner core structure of PGIs from eubacterial and eukaryotic sources, confirms t
215 hod to discriminate three "Tropea Red Onion" PGI ecotypes (TrT, TrMC and TrA) from each other and the
216 , 2,3-dinor 6-keto PGF(1alpha) (PGI-M), only PGI-M was depressed by the COX-2 inhibitor.
217 romboxane (TxA(2)) are biological opposites; PGI(2), a vasodilator and inhibitor of platelet aggregat
218 hacin or by genetic inactivation of COX-1 or PGI(2) synthase with small interfering (si)RNA.
219  threonine, in place of a glutamine in other PGI enzymes, which could permit rotation of the C-2-C-3
220  AMs to a much greater degree than the other PGI(2) analogs and more closely resembled the effects of
221                        Mice that overexpress PGI(2) synthase selectively in bronchial epithelium are
222 post-injury treatment with the ZJ-43 prodrug PGI-02776 reduces both acute neuronal pathology and long
223 y important stable analogues of prostacyclin PGI(2), namely benzindene prostacyclins, has been achiev
224                                Prostacyclin (PGI(2)) and thromboxane (TxA(2)) are biological opposite
225                                Prostacyclin (PGI(2)) is a major PG with antiapoptotic activity and is
226                                Prostacyclin (PGI(2)) is the major prostaglandin generated downstream
227                                Prostacyclin (PGI(2)) is widely used to treat pulmonary arterial hyper
228 n to the production of PGE(2), prostacyclin (PGI(2)), and thromboxane A(2) in human coronary artery e
229 ular Cyclooxygenase-2 (COX-2), prostacyclin (PGI(2)), restrains atherogenesis, inhibition and deletio
230 s, (c) hypoxia and (d) altered prostacyclin (PGI(2)) and enhanced isoprostane formation.
231 ostanglandin E(2) (PGE(2)) and prostacyclin (PGI(2)) production.
232 othelial nitric oxide (NO) and prostacyclin (PGI(2)) production.
233 n augmented expression of both prostacyclin (PGI(2)) and thromboxane (Tx) synthases in endothelial ce
234 cyclooxygenase (COX)-2 depress prostacyclin (PGI(2)) without a concomitant inhibition of platelet COX
235  suppression of PGHS-2-derived prostacyclin (PGI(2)) and PGE(2).
236 clooxygenase 2 (COX-2)-derived prostacyclin (PGI(2)) is sufficient to explain most elements of the ca
237 normally caused by endothelial prostacyclin (PGI(2)).
238 roduced just prior to labor is prostacyclin (PGI(2)), a smooth muscle relaxant.
239 d the subsequent production of prostacyclin (PGI(2)) is an important mechanism responsible for the re
240 latory proteins, production of prostacyclin (PGI(2)), and cAMP were determined.
241 s, likely due to inhibition of prostacyclin (PGI(2)).
242 ched angiotensin II-stimulated prostacyclin (PGI(2))-dependent relaxation into a persistent vasoconst
243 lial cell COX-2 coupled to the prostacyclin (PGI(2)) synthase (PGIS) activates the nuclear receptor p
244 he sugar substrates suggests that pyrococcal PGI has a preference for straight chain substrates and t
245 roduction and is replenished by the reversed PGI reaction.
246 ess observed for the Deltamec/Deltamec/(RNAi)PGI double mutant when compared with the single mutants,
247 ta agonist GW501516 but not by the selective PGI(2) receptor agonist cicaprost.
248     At the time of H. pylori seroconversion, PGI peaked to levels significantly higher than in the ne
249 ation, short-tag pooled genomic indexing (ST-PGI), was also introduced to further improve the economy
250                         In the present study PGI-02776, a newly designed di-ester prodrug of the urea
251 tecting against RSV-induced illness and that PGI(2) is a potential therapeutic target in the treatmen
252                             We conclude that PGI(2) exerts anti-inflammatory action by inhibiting STA
253 al of bacterial enzymes, we demonstrate that PGI-LysAP has broad exopeptidase activity which may enha
254 of PGI(2.) In this study, we determined that PGI(2) analogs modulate dendritic cell (DC) cytokine pro
255 hough there are many studies indicating that PGI/AMF has been implicated in progression of metastasis
256                    We therefore propose that PGI(2)-mediated upregulation of contractile proteins and
257                               We report that PGI(2) analogs (iloprost, cicaprost, treprostinil) diffe
258                           We now report that PGI-02776 (10mg/kg) is neuroprotective when administered
259                          We also report that PGI/AMF degradation is mainly regulated by the ubiquitin
260                 In vitro studies showed that PGI(2) did not affect IL-4 and IL-5 production or the le
261               Molecular analysis showed that PGI/AMF suppressed epithelial marker expressions and enh
262        Together, these findings suggest that PGI(2) plays a key immunoregulatory role by promoting th
263                  These findings suggest that PGI(2) signaling through the IP may exert anti-inflammat
264 Collectively, these experiments suggest that PGI(2), which is generated by endothelial cells during l
265 her, the results presented here suggest that PGI/AMF is involved in oxidative stress-induced cellular
266                      The data suggested that PGI veal has higher variability for most fatty acids tha
267 hese results suggest for the first time that PGI/AMF is a key gene to both EMT in the initiating step
268       Here we show, for the first time, that PGI/AMF overexpression led to an increase in the DNA-bin
269                                          The PGI(2) analogs decreased BMDC production of proinflammat
270                                          The PGI/AMF siRNA caused cells to change shape dramatically
271 hern Italy (Siracusa), have been awarded the PGI (Protected Geographical Indication) recognition as '
272 these effects were strongly inhibited by the PGI/AMF, VEGF, or VEGF receptor inhibitors.
273           In contrast, mice deficient in the PGI(2) receptor IP have exacerbated RSV-induced weight l
274 rved in the thymus of naive mice lacking the PGI(2) receptor IP, as well as in the lungs during aller
275 ces, confirms this enzyme as a member of the PGI superfamily.
276 h muscle cells, similar to the effect of the PGI(2) analog iloprost.
277 deleted mice have shown that ablation of the PGI(2) receptor (the IP) predisposes to an exaggerated r
278               Intramedullary infusion of the PGI(2) receptor agonist increased urine volume and sodiu
279                     Although deletion of the PGI(2) receptor fosters atherogenesis, the importance of
280 f "much better" or "very much better" on the PGI-C.
281 ng that hypoxia-inducible VEGF regulates the PGI/AMF expression.
282 , with energies significantly lower than the PGI/PGII conformations characteristic of polyglycine str
283 nderlying such regulation, we found that the PGI(2) receptor, IP, is preferentially expressed by effe
284                        Signaling through the PGI(2) receptor (IP) has been shown to inhibit inflammat
285 he concentration and time of exposure to the PGI(2) analog iloprost and was blocked by both RO3244794
286                                        Those PGI/AMF siRNA-transfected cells showed epithelial phenot
287 lori acquisition, accompanied by a transient PGI increase, was frequent in this population, especiall
288 n as the catalytic base in the eukaryal-type PGIs.
289 chanisms of these two structurally unrelated PGIs may be similar and based on an enediol intermediate
290 , we sought to define the effects of various PGI(2) analogs on resident alveolar macrophage (AM) and
291                              The vasodilator PGI(2) analog, cicaprost, increased Rap1 activity and de
292 enge remains to identify a mechanism whereby PGI(2) and PGE(2) expression can be suppressed while avo
293 s; however, the molecular mechanism by which PGI/AMF regulates EMT is not known.
294                Furthermore, tumor cells with PGI/AMF deficiency lost their abilities to form tumor ma
295 ification system to authenticate honeys with PGI.
296 se-14 (PARP-14) to be a binding partner with PGI/AMF.
297 an improvement in cognitive performance with PGI-02776 treatment.
298 ransfer of DO11.10 Th2 cells pretreated with PGI(2) resulted in considerably attenuated pulmonary inf
299 genous PGI/AMF, were stably transfected with PGI/AMF small interfering RNA (siRNA).
300 as markedly reduced following treatment with PGI(2), whereas IP-deficient Th2 cells were unaffected a

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top